Van Rampelbergh et al investigate the clinical characteristics and outcomes of vaccine-induced immune thrombocytopenia and thrombosis (VITT) following vaccination with 2 adenovirus vector COVID-19 vaccines: Ad26.COV2.S and ChAdOx1 nCoV-19. No strong evidence for a clinically relevant difference in VITT occurring after either vaccine.
- Rian Van Rampelbergh
- Sue Pavord
- Frank Struyf